Back to Screener

PMGC Holdings Inc. Common Stock (ELAB)

Price$1.77
Growth ScoreC
Momentum ScoreF

Favorite Metrics

Price vs S&P 500 (26W)-114.38%
Price vs S&P 500 (4W)-34.45%
VGM Score29.68
Market Capitalization$8.04M

All Metrics

Book Value / Share (Quarterly)$6.51
P/TBV (Annual)0.22x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-4.33
Price vs S&P 500 (YTD)-105.95%
Gross Margin (TTM)32.69%
Net Profit Margin (TTM)-828.90%
EPS (TTM)$-245.60
10-Day Avg Trading Volume1.56M
EPS Excl Extra (TTM)$-245.60
EPS (Annual)$-380.73
ROI (Annual)-83.65%
Gross Margin (Annual)31.40%
Cash / Share (Quarterly)$7.79
Revenue Growth QoQ (YoY)-45.79%
ROA (Last FY)-60.21%
Revenue Growth TTM (YoY)141.08%
EBITD / Share (TTM)$-67.23
Operating Margin (TTM)-626.42%
Cash Flow / Share (Annual)$-79.08
P/B Ratio0.64x
P/B Ratio (Quarterly)0.55x
Net Income / Employee (Annual)$-242,100
EV / Revenue (TTM)-0.46x
Net Interest Coverage (TTM)-16.10x
ROA (TTM)-70.28%
EPS Incl Extra (Annual)$-380.73
Current Ratio (Annual)1.74x
Quick Ratio (Quarterly)1.38x
3-Month Avg Trading Volume5.41M
52-Week Price Return-99.01%
Revenue / Employee (TTM)$39,800
Tangible BV / Share (Quarterly)$4.55
P/S Ratio (Annual)13.63x
Asset Turnover (Annual)0.05x
52-Week High$309.12
EPS Excl Extra (Annual)$-380.73
26-Week Price Return-98.45%
Quick Ratio (Annual)1.60x
13-Week Price Return-76.59%
Total Debt / Equity (Annual)0.18x
Current Ratio (Quarterly)1.45x
Enterprise Value$-587,200
Asset Turnover (TTM)0.07x
Revenue / Employee (Annual)$18,400
Inventory Turnover (Annual)1.59x
Pretax Margin (Annual)-1313.34%
Cash / Share (Annual)$74.03
3-Month Return Std Dev427.99%
Net Income / Employee (TTM)$-347,100
ROE (Last FY)-98.86%
Net Interest Coverage (Annual)-3.45x
EPS Basic Excl Extra (Annual)$-380.73
Receivables Turnover (TTM)5.94x
Total Debt / Equity (Quarterly)0.45x
EPS Incl Extra (TTM)$-245.60
Receivables Turnover (Annual)4.71x
ROI (TTM)-91.93%
P/S Ratio (TTM)6.32x
Revenue / Share (Annual)$29.00
Tangible BV / Share (Annual)$61.28
Price vs S&P 500 (52W)-127.21%
Year-to-Date Return-95.02%
5-Day Price Return-0.56%
EPS Normalized (Annual)$-380.73
ROA (5Y Avg)-200.95%
Net Profit Margin (Annual)-1313.01%
Month-to-Date Return-28.05%
EBITD / Share (Annual)$-331.92
Operating Margin (Annual)-1160.98%
LT Debt / Equity (Annual)0.01x
LT Debt / Equity (Quarterly)0.01x
EPS Basic Excl Extra (TTM)$-245.60
P/TBV (Quarterly)0.79x
P/B Ratio (Annual)0.14x
Inventory Turnover (TTM)0.95x
Pretax Margin (TTM)-831.41%
Book Value / Share (Annual)$97.12
Price vs S&P 500 (13W)-86.33%
Beta-0.28x
Revenue / Share (TTM)$2.86
ROE (TTM)-116.96%
52-Week Low$1.62
gGradeC
mGradeF
vgmGradeD
Show chart for

Industry Peers — Pharmaceuticals(550)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
ELABPMGC Holdings Inc. Common Stock
CF$1.77
LLYEli Lilly & Co.DBB$1082.20
JNJJohnson & JohnsonCCC$223.51
ABBVABBVIE INC.DCC$212.93
MRKMerck & Co., Inc.CCC$115.17
NVSNovartis AGCCC$145.68
AZNAstraZeneca PLCDBC$179.71
NVONovo-Nordisk A/SBBC$44.07
PFEPfizer Inc.BCC$25.63
ABTAbbott LaboratoriesCCD$87.78
TEVATeva Pharmaceutical Industries Limited American Depositary SharesCCC$34.64

About

PMGC Holdings Inc operates in medical aesthetics and biopharmaceutical innovation, with a focus on skin aesthetics, obesity treatment, and metabolic health. The company develops and commercializes products addressing these growing market segments.